Nutra Pharma Corp.
NPHC · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $91 | -$143 | -$217 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $22 | $325 | $40 | $32 |
| Inventory | $24 | $31 | $5 | $8 |
| Other Curr. Assets | $288 | $86 | $153 | $234 |
| Total Curr. Assets | $334 | $534 | $55 | $58 |
| Property Plant & Equip (Net) | $332 | $139 | $159 | $214 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $89 | $108 | $88 | $68 |
| Total NC Assets | $421 | $246 | $246 | $282 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $755 | $780 | $302 | $340 |
| Liabilities | – | – | – | – |
| Payables | $727 | $672 | $599 | $583 |
| Short-Term Debt | $8,121 | $7,678 | $4,726 | $7,426 |
| Tax Payable | $0 | $216 | $216 | $168 |
| Deferred Revenue | $0 | $2,253 | $201 | $123 |
| Other Curr. Liab. | $3,853 | $10,322 | $5,741 | $2,689 |
| Total Curr. Liab. | $12,701 | $21,140 | $11,483 | $10,990 |
| LT Debt | $432 | $517 | $313 | $1,051 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $432 | $517 | $313 | $1,051 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $252 | $78 | $143 | $217 |
| Total Liabilities | $13,132 | $21,658 | $11,796 | $12,041 |
| Equity | – | – | – | – |
| Pref Stock | $12 | $12 | $3 | $3 |
| Common Stock | $7,040 | $7,331 | $6,955 | $5,877 |
| Retained Earnings | -$73,552 | -$81,729 | -$68,633 | -$67,864 |
| AOCI | $470 | $0 | $0 | $0 |
| Other Equity | $53,653 | $53,508 | $50,181 | $50,284 |
| Total Equity | -$12,377 | -$20,878 | -$11,494 | -$11,701 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $755 | $780 | $302 | $340 |
| Net Debt | $8,552 | $8,104 | $5,182 | $8,694 |